{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:37:02Z","timestamp":1791877022769,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.08.065","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T21:43:51Z","timestamp":1536097431000},"page":"6144-6151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination"],"prefix":"10.1016","volume":"36","author":[{"given":"Keith","family":"Morgenstern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan C.","family":"Settembre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracie L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl B","key":"10.1016\/j.vaccine.2018.08.065_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jac\/44.suppl_2.3","article-title":"Epidemiology and pathogenesis of influenza","volume":"44","author":"Zambon","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2018.08.065_b0010","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0264-410X(00)00448-5","article-title":"Influenza vaccines: a review and rationale for use in developed and underdeveloped countries","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"issue":"5796","key":"10.1016\/j.vaccine.2018.08.065_b0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/289373a0","article-title":"Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation","volume":"289","author":"Wiley","year":"1981","journal-title":"Nature"},{"issue":"5796","key":"10.1016\/j.vaccine.2018.08.065_b0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2018.08.065_b0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2002.1625","article-title":"Mechanism of neutralization of influenza virus infectivity by antibodies","volume":"302","author":"Knossow","year":"2002","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2018.08.065_b0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J Biol Stand"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2018.08.065_b0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-1135(93)90027-5","article-title":"Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines","volume":"37","author":"Williams","year":"1993","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.08.065_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.07.060","article-title":"Validation of alternative potency assays for influenza vaccines requires clinical studies","author":"Rowlen","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2018.08.065_b0045","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.1093\/infdis\/136.Supplement_3.S397","article-title":"Correlation of laboratory studies with clinical responses to A\/New Jersey influenza vaccines","volume":"136","author":"Ennis","year":"1977","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.08.065_b0050","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/clinids\/5.4.723","article-title":"Summary of clinical trials of inactivated influenza vaccine \u2013 1978","volume":"5","author":"La Montagne","year":"1983","journal-title":"Rev Infect Dis"},{"issue":"83","key":"10.1016\/j.vaccine.2018.08.065_b0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/newbio238145a0","article-title":"Crystalline antigen from the influenza virus envelope","volume":"238","author":"Brand","year":"1972","journal-title":"Nat New Biol"},{"key":"10.1016\/j.vaccine.2018.08.065_b0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/vaccines3010090","article-title":"Assaying the Potency of Influenza Vaccines","volume":"3","author":"Minor","year":"2015","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2018.08.065_b0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/irv.12543","article-title":"Standardisation of inactivated influenza vaccines-Learning from history","volume":"12","author":"Wood","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"issue":"6","key":"10.1016\/j.vaccine.2018.08.065_b0070","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1750-2659.2011.00250.x","article-title":"Confronting the next pandemic--workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27\u201329, 2010","volume":"5","author":"Hardy","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2018.08.065_b0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-2836(77)80149-6","article-title":"Crystallization and x-ray diffraction studies on the haemagglutinin glycoprotein from the membrane of influenza virus","volume":"112","author":"Wiley","year":"1977","journal-title":"J Mol Biol"},{"issue":"6492","key":"10.1016\/j.vaccine.2018.08.065_b0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/371037a0","article-title":"Structure of influenza haemagglutinin at the pH of membrane fusion","volume":"371","author":"Bullough","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.08.065_b0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2018.08.065_b0090","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1099\/0022-1317-69-11-2785","article-title":"Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion","volume":"69","author":"Ruigrok","year":"1988","journal-title":"J Gen Virol"},{"issue":"29","key":"10.1016\/j.vaccine.2018.08.065_b0095","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1016\/j.vaccine.2016.04.091","article-title":"Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings","volume":"34","author":"Wen","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.08.065_b0100","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1073\/pnas.79.4.968","article-title":"Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion","volume":"79","author":"Skehel","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2018.08.065_b0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0042-6822(86)90210-2","article-title":"Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes","volume":"155","author":"Ruigrok","year":"1986","journal-title":"Virology"},{"issue":"41","key":"10.1016\/j.vaccine.2018.08.065_b0110","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1016\/j.vaccine.2015.08.077","article-title":"Conformationally selective biophysical assay for influenza vaccine potency determination","volume":"33","author":"Wen","year":"2015","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2018.08.065_b0115","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.vaccine.2018.04.021","article-title":"Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity","volume":"36","author":"Wen","year":"2018","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2018.08.065_b0120","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.vaccine.2006.01.046","article-title":"Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method","volume":"24","author":"Kapteyn","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2018.08.065_b0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.chroma.2006.04.003","article-title":"Rapid and selective characterization of influenza virus constituents in monovalent and multivalent preparations using non-porous reversed-phase high performance liquid chromatography columns","volume":"1123","author":"Garcia-Canas","year":"2006","journal-title":"J Chromatogr A"},{"issue":"20","key":"10.1016\/j.vaccine.2018.08.065_b0130","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.vaccine.2008.03.014","article-title":"Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry","volume":"26","author":"Williams","year":"2008","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2018.08.065_b0135","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1021\/ac4040778","article-title":"Quantification of viral proteins of the avian H7 subtype of influenza virus: an isotope dilution mass spectrometry method applicable for producing more rapid vaccines in the case of an influenza pandemic","volume":"86","author":"Santana","year":"2014","journal-title":"Anal Chem"},{"issue":"35","key":"10.1016\/j.vaccine.2018.08.065_b0140","doi-asserted-by":"crossref","first-page":"928","DOI":"10.15585\/mmwr.mm6635a2","article-title":"Update: increase in human infections with novel Asian lineage avian influenza A(H7N9) viruses during the fifth epidemic \u2013 China, October 1, 2016\u2013August 7, 2017","volume":"66","author":"Kile","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2018.08.065_b0145","first-page":"129","article-title":"Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness","volume":"92","author":"WHO","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"14","key":"10.1016\/j.vaccine.2018.08.065_b0150","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.vaccine.2011.12.056","article-title":"Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry","volume":"30","author":"Williams","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.08.065_b0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ab.2009.05.050","article-title":"Optimization of digestion parameters for protein quantification","volume":"393","author":"Norrgran","year":"2009","journal-title":"Anal Biochem"},{"issue":"10","key":"10.1016\/j.vaccine.2018.08.065_b0160","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1021\/ac900367q","article-title":"Amino acid analysis of peptides using isobaric-tagged isotope dilution LC-MS\/MS","volume":"81","author":"Woolfitt","year":"2009","journal-title":"Anal Chem"},{"issue":"7459","key":"10.1016\/j.vaccine.2018.08.065_b0165","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nature12372","article-title":"Receptor binding by an H7N9 influenza virus from humans","volume":"499","author":"Xiong","year":"2013","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:54Z","timestamp":1759400934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":33,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18312040"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}